Valgen 40 mg, 80 mg, 160 or 320 mg FC tablets
PDF Leaflet Revision Date: 03 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension, post-myocardial infarction, and heart failure.
Dosage (summary)
Hypertension: 80-160 mg once daily; Post-MI: start at 20 mg twice daily, titrate to 160 mg twice daily; Heart failure: start at 40 mg twice daily, titrate to 160 mg twice daily.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- Aliskiren
Contraindications
- Hypersensitivity to valsartan
- Severe renal impairment
- Bilateral renal artery stenosis
- History of angioedema
Common side effects
- Hypotension
- Dizziness
- Hyperkalaemia
- Renal failure
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any signs of angioedema immediately
Serious warnings
- Risk of hypotension in volume-depleted patients
- Angioedema risk
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Valgen 40 mg, 80 mg, 160 or 320 mg FC tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
